Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Angelo Alonzo

Showing results (41-50 of 47) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 47 results.
Brain Stimulation|September 3, 2018
Pre-treatment attentional processing speed and antidepressant response to transcranial direct current stimulation: Results from an international randomized controlled trialDonel M Martin, Shawn M McClintock, Scott T Aaronson, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|December 15, 2019
Efficacy and acceptability of transcranial direct current stimulation (tDCS) for major depressive disorder: An individual patient data meta-analysisAdriano H Moffa, Donel Martin, Angelo Alonzo, et al.
The Journal of Cardiovascular Nursing|June 26, 2007
Reducing delay in seeking treatment by patients with acute coronary syndrome and stroke: a scientific statement from the American Heart Association Council on Cardiovascular Nursing and Stroke CouncilDebra K Moser, Laura P Kimble, Mark J Alberts, et al.
Circulation|June 28, 2006
Reducing delay in seeking treatment by patients with acute coronary syndrome and stroke: a scientific statement from the American Heart Association Council on cardiovascular nursing and stroke councilDebra K Moser, Laura P Kimble, Mark J Alberts, et al.
The British Journal of Psychiatry : the Journal of Mental Science|January 7, 2025
Effect of ketamine on anxiety: findings from the Ketamine for Adult Depression StudyNatalie T Mills, Stevan Nikolin, Nick Glozier, et al.
The British Journal of Psychiatry : the Journal of Mental Science|July 6, 2026
Effectiveness and safety of repeat dose subcutaneous ketamine for treatment-resistant depression, and the impact of prior ketamine treatment: open label extension of the KADS studyNick Glozier, Richard Morris, Elizabeth Stratton, et al.
The British Journal of Psychiatry : the Journal of Mental Science|December 18, 2023
Efficacy and safety of a 4-week course of repeated subcutaneous ketamine injections for treatment-resistant depression (KADS study): randomised double-blind active-controlled trialColleen Loo, Nick Glozier, David Barton, et al.
Pageof 5

Showing results (41-50 of 47) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 47 results.
Brain Stimulation|September 3, 2018
Pre-treatment attentional processing speed and antidepressant response to transcranial direct current stimulation: Results from an international randomized controlled trialDonel M Martin, Shawn M McClintock, Scott T Aaronson, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|December 15, 2019
Efficacy and acceptability of transcranial direct current stimulation (tDCS) for major depressive disorder: An individual patient data meta-analysisAdriano H Moffa, Donel Martin, Angelo Alonzo, et al.
The Journal of Cardiovascular Nursing|June 26, 2007
Reducing delay in seeking treatment by patients with acute coronary syndrome and stroke: a scientific statement from the American Heart Association Council on Cardiovascular Nursing and Stroke CouncilDebra K Moser, Laura P Kimble, Mark J Alberts, et al.
Circulation|June 28, 2006
Reducing delay in seeking treatment by patients with acute coronary syndrome and stroke: a scientific statement from the American Heart Association Council on cardiovascular nursing and stroke councilDebra K Moser, Laura P Kimble, Mark J Alberts, et al.
The British Journal of Psychiatry : the Journal of Mental Science|January 7, 2025
Effect of ketamine on anxiety: findings from the Ketamine for Adult Depression StudyNatalie T Mills, Stevan Nikolin, Nick Glozier, et al.
The British Journal of Psychiatry : the Journal of Mental Science|July 6, 2026
Effectiveness and safety of repeat dose subcutaneous ketamine for treatment-resistant depression, and the impact of prior ketamine treatment: open label extension of the KADS studyNick Glozier, Richard Morris, Elizabeth Stratton, et al.
The British Journal of Psychiatry : the Journal of Mental Science|December 18, 2023
Efficacy and safety of a 4-week course of repeated subcutaneous ketamine injections for treatment-resistant depression (KADS study): randomised double-blind active-controlled trialColleen Loo, Nick Glozier, David Barton, et al.
Pageof 5